Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

NCT03134352 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Eczema

Interventions

DRUG: ZL-3101
DRUG: Placebo

Sponsor

Zai Lab Pty. Ltd.